These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1137366)

  • 1. Parenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococci.
    Williams DN; Crossley K; Hoffman C; Sabath LD
    Antimicrob Agents Chemother; 1975 Feb; 7(2):153-8. PubMed ID: 1137366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of clindamycin-2-phosphate in ophthalmology (author's transl)].
    Tokuda H; Hatano H; Kayaba T
    Jpn J Antibiot; 1977 Jan; 30(1):107-10. PubMed ID: 14269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India.
    Pal N; Sharma B; Sharma R; Vyas L
    J Postgrad Med; 2010; 56(3):182-5. PubMed ID: 20739762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of clindamycin resistance in erythromycin-resistant, clindamycin susceptible and methicillin-resistant clinical Staphylococcal isolates.
    Kader AA; Kumar A; Krishna A
    Saudi Med J; 2005 Dec; 26(12):1914-7. PubMed ID: 16380772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible clindamycin resistance among clinical isolates of Staphylococci.
    Ciraj AM; Vinod P; Sreejith G; Rajani K
    Indian J Pathol Microbiol; 2009; 52(1):49-51. PubMed ID: 19136780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of inducible clindamycin resistance in staphylococci by disk diffusion induction test.
    Chelae S; Laohaprertthisarn V; Phengmak M; Kongmuang U; Kalnauwakul S
    J Med Assoc Thai; 2009 Jul; 92(7):947-51. PubMed ID: 19626815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible clindamycin resistance in Staphylococcus species.
    Afridi FI; Zeb M; Hussain A; Farooqi BJ; Murtuza G
    J Coll Physicians Surg Pak; 2014 Jul; 24(7):481-4. PubMed ID: 25052970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic detection of constitutive and inducible clindamycin resistance in clinical isolates of Staphylococcus aureus and coagulase negative Staphylococcus on routine susceptibility plate.
    Fomda BA; Peer MA; Zahoor D; Thokar MA; Nasir RA
    J Commun Dis; 2010 Mar; 42(1):19-26. PubMed ID: 22468547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp.
    Fokas S; Fokas S; Tsironi M; Kalkani M; Dionysopouloy M
    Clin Microbiol Infect; 2005 Apr; 11(4):337-40. PubMed ID: 15760435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Constitutive and inducible clindamycin resistance among nosocomially acquired staphylococci].
    Dizbay M; Günal O; Ozkan Y; Ozcan Kanat D; Altunçekiç A; Arman D
    Mikrobiyol Bul; 2008 Apr; 42(2):217-21. PubMed ID: 18697419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mixed bacterial infections with clindamycin and gentamicin.
    Fass RJ
    J Infect Dis; 1977 Mar; 135 Suppl():S74-9. PubMed ID: 403243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci.
    Fiebelkorn KR; Crawford SA; McElmeel ML; Jorgensen JH
    J Clin Microbiol; 2003 Oct; 41(10):4740-4. PubMed ID: 14532213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
    Schumacher-Perdreau F; Peters G
    Zentralbl Bakteriol; 1995 Oct; 282(4):389-93. PubMed ID: 9810661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and prevalence of inducible clindamycin resistance in staphylococci.
    Yilmaz G; Aydin K; Iskender S; Caylan R; Koksal I
    J Med Microbiol; 2007 Mar; 56(Pt 3):342-345. PubMed ID: 17314364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of chronic osteomyelitis with clindamycin.
    Pontifex AH; McNaught DR
    Can Med Assoc J; 1973 Jul; 109(2):105-7. PubMed ID: 4578855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.
    Arditi M; Yogev R
    Antimicrob Agents Chemother; 1989 Feb; 33(2):245-7. PubMed ID: 2719468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the D test method to detect inducible clindamycin resistance in coagulase negative staphylococci (CoNS).
    Perez LR; Caierão J; Antunes AL; d'Azevedo PA
    Braz J Infect Dis; 2007 Apr; 11(2):186-8. PubMed ID: 17625757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure.
    Levin TP; Suh B; Axelrod P; Truant AL; Fekete T
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1222-4. PubMed ID: 15728934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.